416 POSTER Phase I trial of ixabepilone administered as a 24-hour infusion in patients with advanced solid malignancies: updated safety profile and maximum tolerated dose

✍ Scribed by A.R. Tan; T. Mekhail; M.J. Edelman; L.C. Iacono; M. Messina; O.C. Trifan

• Book ID: 119599572
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 59 KB
• Volume: 6
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(08)72350-4